| Dr Reginald M Davis Jr, MD | |
|
5 Executive Cir, Savannah, GA 31406-3345 | |
| (912) 355-2400 | |
| (912) 355-5324 |
| Full Name | Dr Reginald M Davis Jr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 40 Years |
| Location | 5 Executive Cir, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528009107 | NPI | - | NPPES |
| 000509418M | Medicaid | GA | |
| 000509418K | Medicaid | GA | |
| 10058694 | Other | GA | AMERIGROUP |
| 000509418L | Medicaid | GA | |
| 000509418J | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 027720 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Josephs Candler Urgent Care Centers Llc | 5092058016 | 40 |
News Archive
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain.
New discoveries in the field of cognitive neuroscience hold great promise for improving current teaching methods. Yet there is a significant gap between such scientific discoveries and the application of this knowledge in the classroom.
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.
› Verified 9 days ago
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20130930000326 |
News Archive
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain.
New discoveries in the field of cognitive neuroscience hold great promise for improving current teaching methods. Yet there is a significant gap between such scientific discoveries and the application of this knowledge in the classroom.
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.
› Verified 9 days ago
| Entity Name | St Josephs Candler Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922580133 PECOS PAC ID: 5092058016 Enrollment ID: O20190515000494 |
News Archive
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain.
New discoveries in the field of cognitive neuroscience hold great promise for improving current teaching methods. Yet there is a significant gap between such scientific discoveries and the application of this knowledge in the classroom.
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Reginald M Davis Jr, MD 5 Executive Cir, Savannah, GA 31406-3345 Ph: (912) 355-2400 | Dr Reginald M Davis Jr, MD 5 Executive Cir, Savannah, GA 31406-3345 Ph: (912) 355-2400 |
News Archive
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain.
New discoveries in the field of cognitive neuroscience hold great promise for improving current teaching methods. Yet there is a significant gap between such scientific discoveries and the application of this knowledge in the classroom.
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.
› Verified 9 days ago
Bradley Post, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 | |
Eriny Hanna, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 615-482-7119 | |
Donald Paul Taylor, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4700 Waters Ave, Emergency Department, Savannah, GA 31404 Phone: 912-350-3849 | |
Matthew Joseph Weis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5353 Reynolds St, Savannah, GA 31405 Phone: 912-819-6000 | |
Ruth Pannell Crider, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5 Executive Cir, Savannah, GA 31406 Phone: 912-355-2400 Fax: 912-355-5324 | |
Robert Risch, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 | |
Mary Kay Ross, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 |